GLIATECH INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GLIATECH INC, 10-Q, EX-10.3, 2000-11-14
Next: U S PHYSICAL THERAPY INC /NV, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                             445
<SECURITIES>                                    10,303
<RECEIVABLES>                                    3,718
<ALLOWANCES>                                        43
<INVENTORY>                                      4,739
<CURRENT-ASSETS>                                20,092
<PP&E>                                           6,203
<DEPRECIATION>                                   2,942
<TOTAL-ASSETS>                                  26,131
<CURRENT-LIABILITIES>                            4,886
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            96
<OTHER-SE>                                      21,149
<TOTAL-LIABILITY-AND-EQUITY>                    26,131
<SALES>                                          6,087
<TOTAL-REVENUES>                                 6,144
<CGS>                                            2,386
<TOTAL-COSTS>                                    2,386
<OTHER-EXPENSES>                                10,701
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (6,677)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,676)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,790)
<EPS-BASIC>                                     (0.70)
<EPS-DILUTED>                                   (0.70)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission